As of February 13, 2026, our covered-call stock portfolio has decreased slightly by -0.33% and closed at $11,069.
Since I couldn’t continue with weekly NVDA spread trades — having already rolled them out to the February 27 expiry — I focused elsewhere last week and reopened our PFE position.
I consider Pfizer a core dividend holding, so I initiated a bull put credit spread and used the premium to purchase 0.5 shares, adding incrementally to our dividend portfolio.
Depending on how this trade develops, I may start selling biweekly or monthly options on PFE to systematically build the position toward 100 shares.
Why I Added Pfizer (PFE) Back to My Portfolio
I initiated the position after closing our Shell trade early. With some capital freed up for a similar-sized setup, PFE looked like a reasonable candidate: a company I already understand, with a solid dividend, and potential to rebound toward its previous $35–45 range. Not a price prediction!
Our covered call portfolio is up 3.32% YTD, slightly outperforming the S&P 500 (-0.33%) and NVDA (-3.21%) YTD.
Current options positions:
- NVDA Feb 27, 2026 170/150 Bull Put Credit Spread
- 2X BMY MAR 20, 2026 50/46 Bull Put Credit spread
- PFE FEB 20, 2026 26.5/25 Cash-Secured Put
- NVDA JUNE 18, 2026 $116 Covered Call
One of the primary goals of our covered call stock portfolio is to gradually reduce debt while maintaining a long position of 100 shares in NVDA. Notably, we earned $14 in options premium this week. If we can consistently average that amount, it would take approximately 279 weeks to fully eliminate our margin debt of $3,919. I’d be quite happy to eliminate this margin debt in 2026 without selling any stock - let’s see how it goes.
Looking ahead to next week (s), I will be closely monitoring the PFE 26.5/25 and NVDA $170/150 put spreads . Should any of our positions come under pressure, the plan is to roll them forward—ideally for a credit.
Never miss an update! Get weekly insights delivered to your inbox—subscribe to the Covered Calls with Reinis Fischer newsletter
